CLARISSA ALVARADO: Open Payments
NPI 1952934747 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$924 in 28 payments from 7 companies in 2025. Trend: 2023 $772 · 2024 $1,377 · 2025 $924
Food & beverage: $855Education: $69
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 8 | $337 |
| ABBVIE INC. | 8 | $219 |
| GENZYME CORPORATION | 8 | $152 |
| Galderma Laboratories, L.P. | 1 | $103 |
| Janssen Biotech, Inc. | 1 | $69 |
| Lilly USA, LLC | 1 | $27 |
| Amgen Inc. | 1 | $18 |
Products named: OPZELURA, SKYRIZI, DUPIXENT, NEMLUVIO, TREMFYA, RINVOQ, TALTZ, Otezla.
Industry payments across CA — which companies pay providers there.
